Knockout mouse: engineered loss-of-function models in biomedical research

How knockout mice are produced

The classical method uses gene targeting in embryonic stem (ES) cells followed by the production of chimeric animals and breeding to establish a line that carries the mutation in every cell. Core steps typically include:

• Designing a DNA construct that alters or replaces the target sequence in ES cells (targeting construct).
• Selecting ES cells in which homologous recombination has occurred (ES cell selection).
• Injecting modified ES cells into host blastocysts to create chimeras (blastocyst injection).
• Breeding chimeras to produce animals carrying the mutation in the germline (germline transmission).

Because some gene knockouts cause embryonic lethality or widespread defects, researchers developed conditional techniques (for example, Cre‑Lox systems) that allow gene disruption in specific tissues or at particular times. In recent years, genome editing technologies such as CRISPR/Cas9 have greatly accelerated the generation of knockout animals across multiple species.

History and development

The first mammalian gene knockouts in mice were reported in the late 1980s, a breakthrough recognized by the Nobel Prize in Physiology or Medicine awarded in 2007 to scientists who developed gene targeting in mice (Capecchi, Evans, Smithies). For many years mice were the principal mammalian species amenable to this approach, and only more recently have reliable gene‑editing methods been adapted to species such as rats (rats and later species). Technical refinements and alternative strategies have continued to expand the power and precision of knockout approaches.

Uses and importance

Knockout mice are used for multiple purposes in biology and medicine:

• Assigning likely functions to genes identified by sequencing projects (functional genomics).
• Creating animal models of human diseases to study pathogenesis and progression (disease modelling).
• Validating drug targets and testing therapeutic interventions (preclinical testing).
• Investigating developmental processes, behaviour and physiology under controlled genetic changes (technology applications).

Because mice share many physiological and genetic similarities with humans, loss‑of‑function mutations in mice often yield insights that are relevant to human health, though not every mouse phenotype predicts human outcomes exactly.

Limitations, distinctions and practical considerations

Important caveats apply when interpreting knockout phenotypes. Genetic redundancy can mask the effect of a deleted gene if related genes compensate. Some knockouts produce early lethality, preventing study of adult roles unless conditional approaches are used. Background strain differences, environment and husbandry can influence observed traits, so careful controls and replication are essential. The field also distinguishes between full knockouts, conditional knockouts, hypomorphs (partial loss), and knock‑ins (precise sequence changes).

Legal, ethical and translational notes

Patents and licensing have covered many aspects of mouse gene‑targeting technologies and specific mutant lines, which affects distribution and use (patents and licensing). Ethical oversight governs the creation and use of genetically modified animals, requiring justification, welfare considerations and review. Despite limitations, knockout mice remain a powerful experimental resource that has shaped modern genetics, physiology and drug development (method summaries, historical accounts, foundational work, technical resources, resource guides, protocol collections, species comparisons, clinical relevance, human relevance, research applications, nobel materials).